Answering Key Questions About COVID-19 Vaccines
2020; American Medical Association; Volume: 324; Issue: 20 Linguagem: Inglês
10.1001/jama.2020.20590
ISSN1538-3598
AutoresJesse L. Goodman, John D. Grabenstein, M. Miles Braun,
Tópico(s)COVID-19 Pandemic Impacts
ResumoAnswering Key Questions About COVID-19 VaccinesThe US government is investing in rapid development of vaccinesagainstcoronavirusdisease2019(COVID-19),several relying on new technologies. 1In the US, 4 vaccine candidates are in phase 3 studies with initial results expected soon.If studies succeed, 1 or more vaccines may become available within a few months.Clinicians are likely among the first to be offered COVID-19 vaccines and have a key role in helping patients make decisions about vaccination. 2Providing evidence-based information will be particularly important in an environment of polarization and mistrust.This Viewpoint focuses on common questions patients are likely to ask about COVID-19 vaccines.
Referência(s)